Company · CIK 1671927
Immunocore Holdings plc
| CIK | 1671927 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | IMCR (Nasdaq) |
| First annual or quarterly report | 2021-03-25 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-278120 | 2024-03-21 | 2024-03-21 | 1 | |
| 333-252166 | 2021-01-15 | 2021-02-08 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-03-21 | S-3ASRShelf registered | 333-278120 | 0001140361-24-014427 |
| 2022-09-09 | 424B5Shelf takedown | 333-264105 | 0001140361-22-032910 |
| 2021-02-08 | 424B4Final prospectus | 333-252166 | 0001140361-21-003664 |
| 2021-02-04 | EFFECTDeclared effective | 333-252487 | 9999999995-21-000461 |
| 2021-02-04 | EFFECTDeclared effective | 333-252166 | 9999999995-21-000445 |
| 2021-02-03 | F-1/AAmendment | 333-252166 | 0001140361-21-003273 |
| 2021-02-01 | F-1/AAmendment | 333-252166 | 0001140361-21-002787 |
| 2021-01-15 | F-1Registration filed | 333-252166 | 0001140361-21-001312 |
| 2020-11-17 | DRSDraft made public | 377-03790 | 0001140361-20-025798 |